Ntara to unveil 2024 US Manufacturers Digital Benchmarking Study at PIMpoint Chicago
April 24, 2024 08:00 ET
|
Ntara
Ntara debuts its inaugural 2024 Manufacturers Digital Commerce Benchmarking Study during a keynote presentation at inriver PIMpoint in Chicago.
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
April 24, 2024 07:00 ET
|
atai Life Sciences
The BPL-003 Phase 2a trial is an open-label study investigating BPL-003 as both monotherapy and adjunctive to SSRIs in patients with Treatment Resistant Depression.Initial results from the recently...
[Latest] Global Flavours and Fragrances Market Size/Share Worth USD 50.7 Billion by 2033 at a 4.82% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 23, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, April 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Flavours and Fragrances Market Size, Trends and Insights By Type (Flavours,...
Pixalate Releases Q1 2024 Mobile Supply-Side Platform (SSP) Global Market Share Rankings for Apple App Store Apps: Google AdExchange No. 1 in North America (14%), Followed by Magnite (8%)
April 22, 2024 15:05 ET
|
Pixalate Inc.
LONDON, April 22, 2024 (GLOBE NEWSWIRE) -- Pixalate, the market-leading fraud protection, privacy, and compliance analytics platform for Connected TV (CTV) and Mobile Advertising, today released the...
Leading Impact Investors and Philanthropists Convene for Mission Investors Exchange 2024 National Conference in Los Angeles in May
April 22, 2024 11:40 ET
|
Mission Investors Exchange
Los Angeles, April 22, 2024 (GLOBE NEWSWIRE) -- The Mission Investors Exchange 2024 National Conference will bring more than 750 philanthropy and impact investing leaders from across the country to...
UPDATE - New Study Reveals Potential Treatment for Neurological Lyme Disease
April 19, 2024 12:45 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study...
New Study Reveals Potential Treatment for Neurological Lyme Disease
April 18, 2024 11:00 ET
|
Bay Area Lyme Foundation
PORTOLA VALLEY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, recently announced publication of a laboratory study showing...
OPTIZMO™ Releases 2023 Email Opt-Out Infographic
April 18, 2024 09:00 ET
|
OPTIZMO Technologies, LLC
The infographic presents unique insights and data from hundreds of millions of opt-out requests, focusing on timing, geographic location, and device usage.
Renewables and nascent low-carbon technologies most exposed to high interest rates
April 18, 2024 06:25 ET
|
Wood Mackenzie
NEWS RELEASE Renewables and nascent low-carbon technologies most exposed to high interest rates Policymakers should...
atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
April 17, 2024 07:00 ET
|
atai Life Sciences
BPL-003 is Beckley Psytech’s novel patent-protected benzoate salt formulation of 5-MeO-DMT that is administered intranasally.BPL-003 was shown to be safe and well-tolerated with a predictable...